PMID: 9546673Apr 18, 1998Paper

Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function

European Journal of Biochemistry
S W GalS Nishikawa

Abstract

A high-affinity RNA aptamer to human activated protein C (APC) was selected from a pool of random sequences using in vitro selection. Activated protein C, a trypsin-like serine protease plays an important role along with thrombin as a regulator in blood clotting cascade. After seven rounds of selection and amplification, a single predominant nucleic acid sequence APC-167, a 167-base oligonucleotide with a random sequence core of 120 bases, was obtained. The selected aptamer did not bind to thrombin or factor Xa and thus demonstrated specificity to APC. Furthermore, this aptamer was a non-competitive inhibitor to the cleavage reaction of a fluorogenic substrate catalyzed by APC. The inhibition constant (Ki) of APC-167 was 83 nM. The 99-base oligonucleotide (APC-99) derived from APC-167 by deleting both primer binding sites, was also found to inhibit APC strongly (Ki = 137 nM). Two stem-loop structures and at least one G x U wobble base pair in the stem were elucidated as important structural motifs for binding.

Citations

Oct 31, 2006·Analytical and Bioanalytical Chemistry·Subash Chandra Bose Gopinath
Jul 2, 2010·Nature Reviews. Drug Discovery·Anthony D KeefeAndrew Ellington
Jul 15, 2006·Nucleosides, Nucleotides & Nucleic Acids·Fumiko NishikawaSatoshi Nishikawa
Aug 8, 2002·Diabetes Technology & Therapeutics·Amy Yan, Andrew D Ellington
Jan 16, 2007·BMC Bioinformatics·Yukiko YagiKoji Sode
Mar 14, 2013·PloS One·Jennifer A MartinWeihong Tan
Dec 19, 2000·Biochemical and Biophysical Research Communications·J HwangS Nishikawa
Apr 20, 2010·Expert Review of Cardiovascular Therapy·Wiktor KuliczkowskiVictor Serebruany
Sep 1, 2007·Expert Opinion on Drug Discovery·Aniela WochnerMartina Rimmele
Dec 7, 2007·Thrombosis Research·Subash Chandra Bose Gopinath
Dec 19, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·S Shetty, K Ghosh
Feb 12, 2014·Thrombosis Research·Olivier SperandioGerry A F Nicolaes
Nov 30, 2000·Chemistry & Biology·S D SeiwertO C Uhlenbeck
Dec 10, 2014·Blood Cells, Molecules & Diseases·Shrimati D Shetty, Kanjaksha Ghosh
Oct 10, 2014·PloS One·András SzilágyiEörs Szathmáry
Jun 9, 2006·Journal of Biomolecular Screening·Joonsung Hwang, Satoshi Nishikawa
Apr 1, 2014·Colloids and Surfaces. B, Biointerfaces·Arzum Erdem, Gulsah Congur
Dec 4, 2014·Chemical Communications : Chem Comm·Nasim Shahidi HamedaniJens Müller
Feb 8, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Stanislaw MalickiGrzegorz Dubin
Feb 11, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Piao-Ping Hu, Kun-He Zhang
May 1, 2021·International Journal of Molecular Sciences·Max LiuYolanda M Fortenberry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.